Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.39 |
| ▸ | MASP2 | O00187 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.35 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1431704 | 0.94 | MASP2 (0.43) | MALT1MASP2NLNMMP2 | |
| SCHEMBL3139300 | 0.85 | MASP2 (0.47) | MALT1MASP2EPHX2NLNROCK2 | |
| SCHEMBL1431986 | 0.85 | MASP2 (0.42) | MASP2KCNH2 | |
| SCHEMBL1907931 | 0.84 | BACE1 (0.40) | MASP2 | |
| SCHEMBL1431885 | 0.84 | HPGD (0.39) | MALT1MASP2 | |
| SCHEMBL1432596 | 0.84 | MASP2 (0.39) | MASP2EPHX2KCNH2 | |
| SCHEMBL3153403 | 0.84 | MASP2 (0.45) | MASP2EPHX2NLNROCK2KCNH2 | |
| SCHEMBL1432359 | 0.84 | F2 (0.48) | — | |
| SCHEMBL1431838 | 0.83 | METAP2 (0.39) | MASP2EPHX2KCNH2 | |
| SCHEMBL1901816 | 0.83 | MASP2 (0.39) | MASP2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2300428-A1 | AMINOPYRIDINE DERIVATIVES | Vantia Limited (GB) | 2011-03-30 | — | — | EP | disclosed |
| WO-2009133348-A1 | AMINOPYRIDINE DERIVATIVES | VANTIA LIMITED (GB) | 2009-11-05 | — | — | WO | disclosed |